Indovet Life Sciences Private Limited
About Indovet Life Sciences Private Limited
Data last updated:
Indovet Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2020PTC146012. Its GSTIN is 36ABFCS0236B1ZU (Telangana).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Radhika Ratakonda and Srinivas Ramineni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot.No 17 53 Flat No 401 Chanukya Enclave Kukatpally, Hyderabad, Telangana, India – 500085.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.02 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹55.97 Lakh (net margin -11.2%) and EBITDA of -₹52.76 Lakh (EBITDA margin -10.5%). Revenue has grown at a compounded annual rate (CAGR) of 156% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indovet Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot.No 17 53 Flat No 401 Chanukya Enclave Kukatpally, Hyderabad, Telangana, India – 500085
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Indovet Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indovet Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indovet Life Sciences Private Limited, buy the company report.
Financials of Indovet Life Sciences Private Limited
FY 2025 filings availableIndovet Life Sciences Private Limited reported revenue of ₹5.02 Cr (up 1704% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 156% over three years. EBITDA fell 195% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹52.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹55.97 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.5% | ||||
| Net Profit Margin | -11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indovet Life Sciences Private Limited, buy the company report.
Board of directors of Indovet Life Sciences Private Limited
Indovet Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Radhika Ratakonda | Additional Director | 12 Jun 2023 | 3 Years 4 Months | Current |
| Srinivas Ramineni | Additional Director | 12 Jun 2023 | 3 Years 4 Months | Current |
Peer comparison
Indovet Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Robust Aerotech Private Limited | ₹5.03 Cr (FY 2025) | 17.0% | Noida, Uttar Pradesh, India | |||
| Laxon Drugs Private Limited | ₹5.02 Cr (FY 2025) | 25.0% | Chandigarh, India | |||
| Woniry Electronics Private Limited | ₹5.02 Cr (FY 2024) | 411485.0% | Noida, Uttar Pradesh, India | |||
| Shakti Chemicoat Private Limited | ₹5.02 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Hygeia Pharmaceuticals Mfg. Private Limited | ₹5.02 Cr (FY 2024) | 0.0% | Kolkata, West Bengal, India | |||
| Indovet Life Sciences Private Limitedthis company | ₹5.02 Cr (FY 2025) | -₹55.97 Lakh | -11.2% | 1704.0% | Hyderabad, Telangana, India | |
| Ayursatva Herbals Private Limited | ₹5.02 Cr (FY 2024) | 21.0% | Indore, Madhya Pradesh, India | |||
| Aura Herbal Private Limited | ₹5.02 Cr (FY 2024) | 7.0% | New Delhi, Delhi, India | |||
| J.S. Coatings Private Limited | ₹5.01 Cr (FY 2025) | 11.0% | Faridabad, Haryana, India | |||
| Pure Pharma Limited | ₹5.01 Cr (FY 2024) | 429.0% | Indore, Madhya Pradesh, India | |||
| Daivya Salt and Chemicals Private Limited | ₹5.01 Cr (FY 2025) | -43.0% | Gandhidham, Gujarat, India |
To see the full peer comparison of Indovet Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indovet Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indovet Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Indovet Life Sciences Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Indovet Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABFCS0236B1ZU | Telangana | Active | 02 Jan 2021 |
To see the full GST registrations and return filing status of Indovet Life Sciences Private Limited, buy the company report.
Recent activity
Indovet Life Sciences Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Krishna Murthy Raju Manthena ceased to be Director on 20 Mar 2024.
Frequently asked questions
Indovet Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2020 (6+ years old) and is registered under CIN U24304TG2020PTC146012.
Indovet Life Sciences has 2 current directors:
- Radhika Ratakonda - Additional Director
- Srinivas Ramineni - Additional Director
The latest financial statements of Indovet Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Indovet Life Sciences is 36ABFCS0236B1ZU, registered in Telangana.
The CIN (Corporate Identification Number) of Indovet Life Sciences is U24304TG2020PTC146012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indovet Life Sciences was incorporated on 18 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Indovet Life Sciences by revenue are Robust Aerotech Private Limited, Laxon Drugs Private Limited, Woniry Electronics Private Limited, Shakti Chemicoat Private Limited, Hygeia Pharmaceuticals Mfg. Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Krishna Murthy Raju Manthena ceased to be Director on 20 Mar 2024. Prathima Pathapati ceased to be Director on 20 Mar 2024. Radhika Ratakonda was appointed as Additional Director on 12 Jun 2023. Indovet Life Sciences has 4 board changes on record in total.
The registered office of Indovet Life Sciences is at Plot.No 17 53 Flat No 401 Chanukya Enclave Kukatpally, Hyderabad, Telangana, India – 500085.
Indovet Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Indovet Life Sciences is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
